SK13692002A3 - Použitie MIA a jeho fragmentov - Google Patents

Použitie MIA a jeho fragmentov Download PDF

Info

Publication number
SK13692002A3
SK13692002A3 SK1369-2002A SK13692002A SK13692002A3 SK 13692002 A3 SK13692002 A3 SK 13692002A3 SK 13692002 A SK13692002 A SK 13692002A SK 13692002 A3 SK13692002 A3 SK 13692002A3
Authority
SK
Slovakia
Prior art keywords
mia
peptide
disease
cell
arthritis
Prior art date
Application number
SK1369-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Robert Louis Hubert Nelissen
Gijsbertus Franciscus Maria Verheijden
Original Assignee
Akzo Nobel N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N. V. filed Critical Akzo Nobel N. V.
Publication of SK13692002A3 publication Critical patent/SK13692002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK1369-2002A 2000-03-23 2001-03-15 Použitie MIA a jeho fragmentov SK13692002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201063 2000-03-23
PCT/EP2001/002991 WO2001070253A1 (en) 2000-03-23 2001-03-15 Use of mia in immunotherapy

Publications (1)

Publication Number Publication Date
SK13692002A3 true SK13692002A3 (sk) 2003-02-04

Family

ID=8171248

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1369-2002A SK13692002A3 (sk) 2000-03-23 2001-03-15 Použitie MIA a jeho fragmentov

Country Status (19)

Country Link
US (1) US20030091583A1 (hu)
EP (1) EP1267907A1 (hu)
JP (1) JP2003527435A (hu)
KR (1) KR20020089404A (hu)
CN (1) CN1418105A (hu)
AR (1) AR027694A1 (hu)
AU (1) AU783170B2 (hu)
BR (1) BR0109455A (hu)
CA (1) CA2399028A1 (hu)
CZ (1) CZ20023187A3 (hu)
HU (1) HUP0300997A2 (hu)
IL (1) IL150679A0 (hu)
MX (1) MXPA02008889A (hu)
NO (1) NO20024458L (hu)
NZ (1) NZ520346A (hu)
PL (1) PL358132A1 (hu)
RU (1) RU2002128351A (hu)
SK (1) SK13692002A3 (hu)
WO (1) WO2001070253A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076965A1 (en) * 2002-10-16 2004-04-22 Bosserhoff Anja Katrin MIA-2 protein
US8026354B2 (en) * 2005-11-23 2011-09-27 Institut Pasteur Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
BRPI0706575B8 (pt) * 2006-01-13 2021-05-25 Univ Indiana Res & Tech Corp uso colágeno de tipo v ou um componente antigênico do mesmo, e, método para identificar um paciente em espera de transplante de pulmão para um risco aumentado de rejeição de tecido de órgão transplantado.
EP2307048A4 (en) * 2008-07-16 2012-02-29 Baylor Res Inst HIV VACCINE BASED ON TARGETING OF MAXIMIZED GAG AND NEF ON DENDRITIC CELLS
CN102869679B (zh) * 2010-04-27 2015-11-25 Scil技术股份有限公司 稳定的水性mia/cd-rap制剂
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine
AU2013234815B2 (en) * 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
ITRM20120339A1 (it) * 2012-07-16 2014-01-17 Matteo Bordignon Uso di mia (attività inibitoria melanoma) per il trattamento della iper-pigmentazione cutanea e per lo sbiancamento cosmetico della pelle
CN116327971A (zh) * 2023-03-02 2023-06-27 暨南大学附属第一医院（广州华侨医院） 一种靶向cd74+促炎型巨噬细胞的药物载体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE185152T1 (de) * 1993-07-20 1999-10-15 Roche Diagnostics Gmbh Melanom-inhibierendes protein
EP0972022A2 (en) * 1997-01-21 2000-01-19 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
KR20020089404A (ko) 2002-11-29
NZ520346A (en) 2004-07-30
US20030091583A1 (en) 2003-05-15
RU2002128351A (ru) 2004-03-27
AU783170B2 (en) 2005-09-29
BR0109455A (pt) 2003-06-03
AR027694A1 (es) 2003-04-09
MXPA02008889A (es) 2003-04-25
AU4247601A (en) 2001-10-03
HUP0300997A2 (hu) 2003-07-28
PL358132A1 (en) 2004-08-09
JP2003527435A (ja) 2003-09-16
CN1418105A (zh) 2003-05-14
NO20024458D0 (no) 2002-09-18
WO2001070253A1 (en) 2001-09-27
CA2399028A1 (en) 2001-09-27
IL150679A0 (en) 2003-02-12
NO20024458L (no) 2002-09-18
CZ20023187A3 (cs) 2003-01-15
EP1267907A1 (en) 2003-01-02
WO2001070253A8 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
US8680057B2 (en) Tribonectins
AU744885B2 (en) Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
EP1292621B1 (en) Compositions for treating autoimmune disease
CA2461091A1 (en) Use of hmgb1 for the activation of dendritic cells
AU2002341266A1 (en) Use of HMGB1 for the activation of dendritic cells
IL199316A (en) An antibody is cleared and a kit that includes it for diagnosing retinal dystrophy
HU221348B1 (en) Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
HUT77047A (hu) Szklerózis multiplex kezelésére szolgáló készítmények és kezelések
SK13692002A3 (sk) Použitie MIA a jeho fragmentov
EP1093464A2 (en) Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
KR102553070B1 (ko) 전압개폐 칼륨이온채널 억제 활성능을 갖는 작은상자해파리 기원 펩타이드
US20040072286A1 (en) Extracellular matrix protein
WO2000004917A9 (en) USE OF HC gp-39 IN IMMUNE DISEASES
US20060171944A1 (en) N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response